Notes from Underground – Most read articles for the week ending November 14

The most read non-Tom article this week is The View From The Montana Log-Cabin As Gold Has A Better Week! by Nigel Somerville at number 17, or number 24 with Bearcasts.

Most Read

1. 3 Questions that Kefi should be answering
   

   Gold is behaving itself again and bringing some pre Christmas cheer to we gold bugs. And moist gold shares have responded accordingly. But despite being up by 5% today shares in Kefi Gold & Copper (KEFI) are still only 0.62p, just over half the price of the last placing. The one that Kefi had said just 10 days prior would not be needed. Asa loyal shareholder  I have fired over some questions/suggestions to the company.

2. BREAKING: Has Optibiotix really received 2 takeover approaches or is Lyin' Steve O’Hara just a really naughty boy?
   

   I would imagine that Nomad Liam “the toke” Murray will be spitting into his cornflakes as he considers the latest outburst by Police Time Wastin’ Steve O’Hara, the hapless CEO of cash guzzling Optibiotix (OPTI). Surely AIM Regulation will be incandescent (when I alert them later, as I will)

3. Fraudster Rob Terry plans stockmarket comeback – is the London Stock Exchange bent as a nine bob note?
   

   Rob Terry shorted the shares on The Innovation Group (TIG) which he ran before the stock collapsed as its aggressive accounting and related party deals collapsed. The London Stock Exchange did not care about that scandal and so allowed him to float the Quindell fraud, at one stage worth £3 billion on AIM. More related party transactions, more aggressive accounting.  The FRC thanked me for showing how its accounts were bent from the start despite Terry TWICE threatening me with legal action. Now Terry wants another go.

4. Skins NED appointment – not very diverse & comes with a Bixby Edwards stink
   

   Perhaps it was my goading yesterday but Skinbiotherapeutics (SBTX) has today, finally appointed, a new NED and she appears, at a headline level, credible but…

5. Panmure Liberum on Amaroq – I just do not get its maths
   

   Panmure has left its target price and forecasts unchanged on Amaroq (AMRQ) after 3rd quarter numbers as you can see in the note below. But I really just don’t get it and here’s why I think its maths must be wrong.

6. AIM will lose 4.5% of its entire value in one fell swoop on December 8
   

   The pattern continues. A very few small and low grade companies join AIM. Meanwhile some shitcos leave the Casino  as they are going bust but the killer is that more and more good companies, the ones that give AIM credibility are off as a result of takeovers or to escape the Cesspit by upgrading to the Main Market.

7. Skins – where is the new NED?
   

   I am hopeful that we will get results from Skinbiotherapeutics (SBTX) for the year to June 30, and, more importantly some guidance on this year’s numbers, the cashburn and cash position soon, possibly this week. But…

8. Amaroq: a few thoughts on the idea of a dividend
   

   I am not saying there will be one in 2027 but I think Amaroq (AMRQ) should pay a nominal dividend and it could do so. One reader in particular, a Skinhead with AmaroqDerangementSyndrome,  has argued it cannot, so, after the Q3 numbers yesterday let me address him first.

9. Davion Healthcare PLC a $306m Nasdaq IPO on October 22, 90% down already – have we exported a complete turd ( or worse) to the USA?
   

   Before we all laugh at Nasdaq for allowing this scandalburger to IPO on October 22 I should flag up that Davion Healthcare PLC (US:DAVI) is British and the chaps behind it are very well known to the regulators over here. The shares listed at $12.25- and now trade at $1.19. My target is $0.

10. Reabold & West Newton part 1 – what about the injunction?
    

    I shall turn later on to what Reabold Resources (RBD) says about its key West Newton asset in an RNS. But first what it does not say. The injunction.

The most-listened-to Bearcasts this week were:

1. Tom Winnifrith bearcast: the cost of shagging a Chinese Spy

   In today's podcast I look at Atlas Metals (AMG) and why it is toast, Nvidia and its various "issues", the gold price mentioning en passant Amaroq (AMRQ) and Kefi Gold & Copper (KEFI) and finally Skinbiotherapeutics (SBTX).

2. Tom Winnifrith Bearcast: in Amaroq we trust & AIM's most hated CEO

   I reflect on Nicolas Slater's heroics at Aptamer (APTA) but on why I really do not believe in options at all. Then it is the gold price, the most hated CEO on AIM and finally Amaroq (AMRQ) and today's superb Q3 statement

3. Tom Winnifrith Bearcast: Nigel's right, 4 sectors where I want little or no exposure

   Prompted by Mr Somerville after and afternoon of blackthorn planting and angry stewing I consider 4 sectors where I want little or no exposure.

4. Tom Winnifrith Bearcast: Arguing with foul and menacing scam window cleaners

   I start with the highs and lows of my non work day before looking at Blackbird (BIRD), Optibiotix (OPTI) and the never ending car crash that is Cavendish (CAV)

5. Tom Winnifrith Bearcast: should Andrew Webley come to Sharestock again & will bitcoin have collapsed by then?

   U start with 2 Christmas countdown events and the good news on the Warwick pervert Paul Stainsby. Then it is where next for Bitcoin, 3 bitcoin in Treasury stocks to collapse and whether my NBF should come to Sharestock again - you can book early bird tickets HERE, please do so. Then I discuss boardroom diversity in general and Skinbiotherapeutics (SBTX) and its new Bixby/Edwards tainted NED 

6. Tom Winnifrith Bearcast: Henry Gewanter does pick 'em, why bears matter and Andrew Bell & Jensen Huang, the common link

   I start with poor Henry and then the amazing case of Davion Healthcare PLC which shows why shorters matter when regulators fail abysmally Then it is Nvidia (NVDA) and Red Rock Resources (RRR).

7. Tom Winnifrith Bearcast: how low can bitcoin plunge and how to play it with shares trades

   I am delayed by Welsh Rugby and Jaya's birthday party and a house full of screaming young girls. Then to bitcoin.